Stamford, CT -- (SBWIRE) -- 12/03/2013 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Chelsea Therapeutics International Ltd.(NASDAQ:CHTP), Alliqua Inc(OTCMKTS:ALQAD), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Petroleo Brasileiro Petrobras SA (ADR)(NYSE:PBR.A)
Chelsea Therapeutics International Ltd.(NASDAQ:CHTP) opened the session at $3.85, remained amid the day range of $3.76 - $3.93, and closed the session at $3.88. The stock showed a positive performance of 0.26% in previous trading session. The stock gained a volume of 1.61 million shares and the average volume of the stock remained 1.43 million shares. Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products. It is primarily developing Northera (droxidopa), a therapeutic agent that is used for the treatment of symptomatic neurogenic orthostatic hypotension (Neurogenic OH) in patients with primary autonomic failure, dopamine-ß-hydroxylase, and deficiency and non-diabetic autonomic neuropathy.
Why Should Investors Buy CHTP After The Recent Gain? Just Go Here and Find Out
Alliqua Inc(OTCMKTS:ALQAD) traded with volume of 254,930.00 shares in the prior session and the average volume of the stock remained 82,745.00 shares. The 52 week range of the stock remained $1.66 - $8.44. The stock showed a negative movement of -6.50% and closed its session at $7.77. The market capitalization of the stock remained 55.22 million. Alliqua, Inc., a biopharmaceutical company, focuses on the development, manufacture, and distribution of proprietary transdermal wound care and drug delivery technologies. The company offers water content, electron beam cross-linked, and aqueous polymer hydrogels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.
Why Should Investors Buy ALQAD After the Recent Fall? Just Go Here and Find Out
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) exchanged 3.96 million shares and the average volume remained 5.74 million shares. The stock escalated 2.15% and closed the session at $6.66. The beta of the stock remained -0.42 and the EPS of the stock remained -0.08. The shares outstanding of the stock remained 218.57 million. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
For How Long ARNA will fight for Profitability? Read This Trend Analysis report
Petroleo Brasileiro Petrobras SA (ADR)(NYSE:PBR.A) gained volume of 15.83 million shares, while the average volume remained 8.18 million shares. The stock decreased -9.67% and finished the session Monday at $14.94. The EPS of the stock remained 2.05. The one month of the stock was -15.59% and three month trend remained positive 4.77%. Petroleo Brasileiro SA Petrobras (Petrobras) is a Brazil-based integrated oil and gas company. The Company divides its activities into seven segments: Exploration and Production; Refining, Transportation and Marketing; Gas and Power; Biofuel; Distribution and International. Directly or through its subsidiaries, Petrobras is engaged in the research, extraction, refining, processing.
Has PBR.A Found The Bottom and Ready To Move Up? Find Out Here
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)